Windber Research Institute
- Assets
- $10.2m
- Revenue
- $7.9m
- Investments
- $0.0
- Employees
- 38
- Location
- Windber, PA
- Founding
- 09/2001
- Data as of
- 06/2022
- EIN
- 25-1877336
Organization Overview
Windber Research Institute is located in Windber, PA. The organization was established in 2001. According to its NTEE Classification (B99) the organization is classified as: Education N.E.C., under the broad grouping of Education and related organizations. As of 06/2022, Windber Research Institute employed 38 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Windber Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Windber Research Institute generated $7.9m in total revenue. This organization has experienced exceptional growth, as over the past 3 years, it has increased revenue by an average of 19.8% each year . All expenses for the organization totaled $6.6m during the year ending 06/2022. While expenses have increased by 11.8% per year over the past 3 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE CHAN SOON-SHIONG INSTITUTE OF MOLECULAR MEDICINE AT WINDBER IS COMMITTED TO DISCOVERING MOLECULAR DIAGNOSTIC AND PROGNOSTIC BIOMARKERS AND DEVELOPING ADVANCED DISEASE PREVENTION MEASURES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
BCTR/BCCOE - BREAST CANCER TRANSLATIONAL RESEARCH CENTER OF EXCELLENCEUSING BIOBANKING INDUSTRY STANDARDS AND BEST PRACTICES, THE BCTR SPECIMENS ARE MAINTAINED IN A COLLEGE OF AMERICAN PATHOLOGIST (CAP) ACCREDITED BIOREPOSITORY WITH ESTABLISHED QUALITY MANAGEMENT SYSTEMS THAT ENSURES SUSTAINED QUALITY OF THE STORIED BIOSPECIMENS. THE FACILITY AT WINDBER ALSO PERFORMS QUALITY ASSURANCE STUDIES ON RANDOM BIOSPECIMENS PERIODICALLY, AS OF MAY 2021, THREE COLLECTION SITES CONTRIBUTE BIOSPECIMENS TO THE BIOBANK AND WE HAVE 161, 106 BLOOD ALIQUOTS AND 18,764 SOLID TISSUE ALIQUOTS IN STORAGE, VARIOUS PRESENTATIONS, LECTURES, AND CONFERENCES ON BREAST CANCER WERE ATTENDED. THE PROJECT IS ONGOING.
APOLLO - WRI'S MAIN FUNCTION FOR THE APOLLO PROJECT ARE TO PROVIDE A BIOBANKING CENTER TO STORE AND MANAGE BIOSPECIMEN INVENTORY, ASSESS THE QUALITY OF THE TISSUES AND SUITABILITY FOR RESEARCH PERFORM MOLECULAR EXTRACTIONS, AND PREPARE SAMPLES FOR SHIPMENT, OUR INFORMATICS, INFRASTRUCTURE SYSTEM FACILITIES CLINICOPATHOLOGIC DATA COLLECTION AND MANAGEMENT, SUPPORTS MOLECULAR DATA MANAGEMENT AND INTEGRATES AND RENDERS DATA AVALIABLE FOR RESEARCH. OUR BIOINFORMATICIANS STUDY TO FIND OUT WHETHER THERE ARE MOLECULAR DIFFERENCES BETWEEN PRIMARY INVASIVE BREAST TUMORS FROM YOUNG WOMEN COMPARED TO THOSE FROM OLDER WOMEN AND DETERMINE WHETHER THEY COULD POTENTIALLY EXPLAIN THE OBSERVED OUTCOME DIFFERENCES, WRI HAS A LONG HISTORY OF COLLABORATING WITH WALTER REED NATIONAL MILITARY MEDICAL INITIALLY FOCUSING ON THE CLINICAL BREAST CARE PROJECT (CBCP) AND NOW EXPANDING TO PAN-CANCER STUDIES AND NOW PARTICIPATES IN THE APOLLO STUDY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Dr Patrick Soon-Shiong Board Chair | OfficerTrustee | 2 | $0 |
Charles Kim ESQ Board Secretary | OfficerTrustee | 1 | $0 |
David Sachs Board Treasurer | OfficerTrustee | 1 | $0 |
Eleanor Ramirez Board Member | Trustee | 1 | $0 |
Dr Trudi Brown Board Member | Trustee | 1 | $0 |
Thomas Kurtz President And CEO | OfficerTrustee | 25 | $272,112 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $7,203,707 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $7,203,707 |
| Total Program Service Revenue | $0 |
| Investment income | $208 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $70,983 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $7,887,287 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $1,379,100 |
| Compensation of current officers, directors, key employees. | $693,403 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,498,083 |
| Pension plan accruals and contributions | $16,972 |
| Other employee benefits | $126,507 |
| Payroll taxes | $196,833 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $12,364 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $407,852 |
| Advertising and promotion | $0 |
| Office expenses | $601,459 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $168,105 |
| Travel | $18,066 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $8,972 |
| Interest | $46,526 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $450,759 |
| Insurance | $169,807 |
| All other expenses | $144,655 |
| Total functional expenses | $6,625,431 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,978,693 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $1,286,668 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $133,800 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $257,815 |
| Net Land, buildings, and equipment | $6,510,192 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $10,167,168 |
| Accounts payable and accrued expenses | $638,266 |
| Grants payable | $0 |
| Deferred revenue | $1,494,769 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $1,327,797 |
| Unsecured mortgages and notes payable | $38,650 |
| Other liabilities | $709,776 |
| Total liabilities | $4,209,258 |
| Net assets without donor restrictions | $5,929,417 |
| Net assets with donor restrictions | $28,493 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $10,167,168 |